NOVOLOG PACKAGE INSERT PDF

Learn about NovoLog® mealtime insulin, a man-made rapid-acting insulin for adults and children with diabetes. Read important safety & prescribing info on this. The NovoLog® FlexPen®: a dial-a-dose, pre-filled insulin pen for discreet mealtime management that is easy for patients to use. Review FlexPen® benefits . This Instructions For Use sheet provides an overview of NovoLog® and NovoLog ® FlexPen® for patients. This piece can be given to new patients to provide.

Author: Tojazuru Mazuzil
Country: Madagascar
Language: English (Spanish)
Genre: Automotive
Published (Last): 21 June 2006
Pages: 441
PDF File Size: 19.4 Mb
ePub File Size: 10.8 Mb
ISBN: 142-8-61197-409-6
Downloads: 5214
Price: Free* [*Free Regsitration Required]
Uploader: Kajigami

Selected Important Safety Information. The timing of hypoglycemia may reflect the time-action profile of the insulin formulation. Patients should be observed for signs and symptoms of heart failure.

Glucose monitoring is recommended for all patients with diabetes. Patients using insulin infusion pump therapy must be trained to administer insulin by injection and have alternate insulin therapy available in case of pump failure. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased.

Get emergency medical help if you have: Adverse reactions observed with insulin therapy include hypoglycemia, allergic reactions, local injection site reactions, lipodystrophy, rash, and pruritus. Multiple products within the same therapeutic class may be considered preferred and on the same tier. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia.

Hypoglycemia is the most common adverse effect of insulin therapy. The first and only pen with a memory function and half-unit dosing. More closely matches the body’s physiologic insulin profile than human premix insulin 1,2. Thought leaders talk about bolus insulin therapy, from the role of PPG control in helping to reach A1C goals to improving patient engagement. If heart failure occurs, dosage reduction or discontinuation of the TZD must be considered.

TOP 10 Related  ALBERT KAMYU YAD PDF

A dial-a-dose insulin pen that is proven accurate. Learn about another mealtime insulin option from Novo Nordisk.

Talk to your health care provider about how to manage low blood sugar. Your insulin dose may need to change because of: Lower acquisition costs alone do not necessarily reflect a cost advantage in the novolov of the condition treated because there are other variables that affect relative cost.

You are encouraged to report negative side effects of prescription drugs to the FDA. If heart failure occurs, dosage reduction or discontinuation of the TZD must be considered.

Formulary status is subject to change. A comparison of insulin injection needles on patients’ perception of pain, handling, and acceptability: Do not change your insulin type unless your health care provider tells you to. Malfunction of the insulin pump or insulin infusion set or insulin degradation can rapidly lead to hyperglycemia and ketoacidosis.

Dosed within 15 minutes before or after starting a meal in patients with type 2 diabetes, unlike the required 30 minutes before meals with human premix insulin 1. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. This item is temporarily unavailable to ineert please check back soon.

Selected Important Safety Information. Patients should be observed for packqge and symptoms of heart failure. If heart failure occurs, dosage reduction or discontinuation of the TZD must be considered. Know the type and strength of your insulin. Patients were randomized to self administer insulin injections with one needle type followed by the alternative, each for 7 to 14 days.

TOP 10 Related  MC1648 EPUB DOWNLOAD

These patients may require more frequent blood glucose monitoring and dose adjustments. Intended as a guide.

Prefilled insulin device with reduced injection force: Hypoglycemia is the most common adverse effect of insulin therapy.

Glucose monitoring is recommended for all patients with diabetes and is particularly important for patients using external pump infusion therapy. Monitor potassium levels in inserr at risk for hypokalemia and treat if indicated.

Do not reuse or share your needles with other people. Talk to your doctor about which option may be best for you. Does not pckage Medicaid and Medicaid Part D.

NovoLog® Mix 70/30 — Official Health Care Professionals Website

Select a valid page path. Curr Med Res Opin. Patients using insulin infusion pump therapy must be trained to administer insulin by injection and have alternate insulin therapy available in case of pump failure. The timing of hypoglycemia may reflect the time-action profile of the insulin formulation.

Needles are sold separately and may require a prescription in some states. Use in Specific Populations. These patients may require more frequent blood glucose monitoring and dose adjustments. Monitor potassium levels in patients at risk for hypokalemia and treat if indicated.

Monitor potassium levels in patients at risk for hypokalemia and treat if indicated. Use in Specific Populations. Important Limitations of Use. Patients should be observed for signs and symptoms of heart failure.

Serious packaye effects can lead to death, including:

Author: admin